Evidence map›Paper›PMID 40006668›Full record

ArticleVaccines2025

A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil: Optimizing Strategies for Public Health.

Benedetta Ghezzi, Cristina Valencia, Roberto Dias de Oliveira, Daniel Tsuha, Waldno Lucena Júnior, Alberta Di Pasquale, Morgan Mc Namara, Juliana Senra, Denise Abud, Julio Croda

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Benedetta GhezziTakeda Pharmaceuticals International AG, 8152 Zürich, Switzerland.
Cristina ValenciaTakeda Pharmaceuticals International AG, 8152 Zürich, Switzerland.
Roberto Dias de OliveiraOswaldo Cruz Foundation, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.ORCID 0000-0001-7996-8011
Daniel TsuhaOswaldo Cruz Foundation, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.
Waldno Lucena JúniorMunicipal Health Department of Dourados, Municipal Prefecture of Dourados, Dourados 76051-053, MS, Brazil.
Alberta Di PasqualeTakeda Pharmaceuticals International AG, Singapore 018981, Singapore.ORCID 0000-0002-8566-5057
Morgan Mc NamaraTakeda Pharmaceuticals International AG, 8152 Zürich, Switzerland.
Juliana SenraTakeda Pharmaceuticals International AG, São Paulo 04794-000, SP, Brazil.
Denise AbudTakeda Pharmaceuticals International AG, Singapore 018981, Singapore.
Julio CrodaOswaldo Cruz Foundation, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.ORCID 0000-0002-6665-6825

Funding

Takeda Pharmaceuticals International AG N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

denguemethodologypublic healthTAK-003vaccination

Identifiers

PMID40006668
PMCPMC11860522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.